eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by eHealth, Inc. on September 18, 2018, reporting events that occurred on September 17, 2018. The filing details the entry into a new material definitive agreement regarding corporate financing.
Key Financial Metrics and Debt Structure
The Company established a new secured asset-backed revolving credit facility with the following terms:
- Total Facility Size: $40.0 million.
- Letter of Credit Subfacility: $5.0 million.
- Maturity Date: September 17, 2021.
- Outstanding Balance at Closing: $0 (no loans were drawn as of the closing date).
- Interest Rates: LIBOR plus 3.75% or Base Rate plus 2.75%.
- Commitment Fee: 0.5% per annum on the daily unused portion.
- Upfront Facility Fee: 1.75% of total commitments paid at closing.
- Collateral: Substantially all assets of the Loan Parties (excluding intellectual property).
Material Changes and Covenants
The primary material change is the creation of a new direct financial obligation. The Credit Agreement includes specific financial and operational covenants:
- Financial Covenant: The Company must maintain excess availability of at least $6,000,000 at all times.
- Borrowing Base: Calculated based on 80% of eligible commissions receivables collected in the preceding three months or expected in the succeeding three months, plus 50% of eligible receivables for the succeeding six months (excluding the first three months).
- Restrictions: Negative covenants limit the ability to incur additional debt, grant liens, make investments, or sell assets without exceptions.
Outlook, Risks, and Contingencies
The proceeds from the facility are designated for working capital and general corporate purposes. The filing highlights standard events of default, including payment defaults, cross-defaults with other material indebtedness, breaches of covenants, change in control, and bankruptcy or insolvency events. Upon an event of default, lenders may declare all outstanding principal and accrued interest immediately due and payable.
Investor Verification Checklist
- Verify the current level of "Eligible Commissions Receivables" to determine the actual borrowing capacity under the borrowing base formula.
- Confirm the Company's current cash position to ensure compliance with the $6,000,000 excess availability covenant.
- Review the impact of the 1.75% upfront facility fee on the Company's immediate cash flow.
- Assess the extent of assets pledged as collateral, noting the exclusion of intellectual property.